QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cymabay-therapeutics-deal-may-not-be-needle-moving-for-100b-valued-gilead-but-acquisition-is-reasonably-priced-analyst

Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potenti...

 intercept-announces-new-phase-2-data-showing-significant-impact-of-oca-bezafibrate-combination-on-normalization-of-multiple-key-biomarkers-of-pbc-induced-liver-damage-at-aasld-the-liver-meeting-2023

Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP...

 intercept-announces-new-findings-from-long-term-extension-of-landmark-poise-trial-in-pbc-showing-importance-of-biomarkers-beyond-alp-at-aasld-the-liver-meeting-2023

New analysis demonstrates the impact of OCA on achievement of GGT <3.2×ULN and ALP <1.5×ULNFindings suggest that OCA has ...

 alfasigma-spa-announces-expiration-of-hart-scott-rodino-waiting-period-in-connection-with-pending-acquisition-of-intercept-pharmaceuticals-inc

Alfasigma S.p.A. ("Alfasigma") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust I...

 top-5-health-care-stocks-that-should-keep-you-up-at-night

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

 emas-human-medicines-committee-has-started-a-review-of-the-medicine-ocaliva-study-747-302-failed-to-show-that-ocaliva-was-more-effective-than-placebo-additionally-side-effects-including-serious-ones-occurred-more-frequently-in-patients-treated-with-ocaliva

https://www.ema.europa.eu/en/documents/referral/ocaliva-article-20-procedure-review-ocaliva-started_en.pdf  

 b-riley-securities-downgrades-intercept-pharma-to-neutral-raises-price-target-to-19

B. Riley Securities analyst Mayank Mamtani downgrades Intercept Pharma (NASDAQ:ICPT) from Buy to Neutral and raises the pric...

 rbc-capital-maintains-sector-perform-on-intercept-pharma-raises-price-target-to-19

RBC Capital analyst Brian Abrahams maintains Intercept Pharma (NASDAQ:ICPT) with a Sector Perform and raises the price targe...

 hc-wainwright--co-downgrades-intercept-pharma-to-neutral-announces-19-price-target

HC Wainwright & Co. analyst Ed Arce downgrades Intercept Pharma (NASDAQ:ICPT) from Buy to Neutral and announces $19 pric...

 canaccord-genuity-downgrades-intercept-pharma-to-hold-lowers-price-target-to-19

Canaccord Genuity analyst Edward Nash downgrades Intercept Pharma (NASDAQ:ICPT) from Buy to Hold and lowers the price target...

 why-td-synnex-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results...

 fisker-intercept-pharmaceuticals-immunovant-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in ...

 dow-tumbles-150-points-us-house-prices-rise-in-july

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening T...

 why-is-rare-liver-disease-focused-intercept-pharmaceuticals-stock-trading-higher-today

Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc (NASDAQ: ICPT) for